Aytu Bioscience Stock News

Company Reports Revenue for the Three Months Ended March 31, 2020 of $8.2M, Up 243% Year-over-Year $62.5 Million in Cash and Cash Equivalents as of March 31, 2020 Management to Host Conference Call at

Acerus Pharmaceuticals Corporation (OTCQB:ASPCF) Q1 2020 Earnings Conference Call May 12, 2020 8:30 AM ET Company Participants Bob Motz – Chief Financial Office

Acerus Pharmaceuticals Corporation (“Acerus” or the “Company”) (TSX: ASP; OTCQB: ASPCF) today reported its financial results for the three-month perio

The smid-cap biotech earnings deluge hit Wall Street in the week ended May 9, positively impacting the stocks in the sector. The iShares NASDAQ Biotechnology Index (NASDAQ: IBB)...

Aytu Bioscience Inc (AYTU) closed the most recent trading day at $1.47, moving +1.38% from the previous trading session.

ENGLEWOOD, CO / ACCESSWIRE / May 7, 2020 / Aytu BioScience, Inc. (NASDAQ:AYTU) (the "Company"), a specialty pharmaceutical company focused on commercializing novel products that address significant ..

Pomerantz LLP is investigating claims on behalf of investors of Aytu BioSciences, Inc. (“Aytu” or the “Company”) (NASDAQ: AYTU). Such investors are advised to contact Robert S. Willoughby at

Aytu Bioscience, Inc. (AYTU) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Cedars-Sinai is embroiled in a political battle over Trump's remarks on a potential virus treatment.

The market's still WILD and coronavirus is at the center of it all. So how are coronavirus trades changing and how can you adapt?

Chesapeake Energy (NYSE:CHK) -43% after preparing bankruptcy filing.On Deck Capital (NYSE:ONDK) -19% on Q1 earnings.Capricor Therapeutics (NASDAQ:CAPR) -16%.Capstead Mortgage (NYSE:CMO) -13% on

The U.S. Federal government is working closely with companies and researchers to find treatments and vaccines to overcome the global health crisis. The FDA has been cutting red tape and has launched n

Gainers Naked Brand Group Limited (NASDAQ: NAKD) shares climbed 60.8% to close at $0.78 on Monday after climbing 8% on Friday. Yield10 Bioscience, Inc. (NASDAQ: YTEN) shares...

On Aytu BioScience's (AYTU) upcoming earnings call, investor focus will be on its distribution right to commercialize the COVID-19 IgG/IgM Rapid Test in North America.

Axsome Therapeutics (NASDAQ:AXSM) +44% as Axsome's lead candidate successful in Alzheimer's study.Avadel Pharmaceuticals plc (NASDAQ:AVDL) +34% on positive data on lead drug.Yield10 Bioscience (NA